The results above indicated that inhibition of Survivin expression reduced the proliferation and migration of bladder carcinoma cells, as well as the combination of paProtacL‐Survivin and paCas9‐Survivin systems could maximize the suppression of proliferation and migration. Here, BIRC5 is linked to urinary bladder carcinoma.